SIMULTANEOUS DETERMINATION OF LEVAMISOLE AND OXYCLOZANIDE IN THE PHARMACEUTICAL PREPARATION BY CAPILLARY ELECTROPHORESIS

A. Ahmed, M. Nassar, A. El-Olemy, Mohamed S. Emara
{"title":"SIMULTANEOUS DETERMINATION OF LEVAMISOLE AND OXYCLOZANIDE IN THE PHARMACEUTICAL PREPARATION BY CAPILLARY ELECTROPHORESIS","authors":"A. Ahmed, M. Nassar, A. El-Olemy, Mohamed S. Emara","doi":"10.21608/ajps.2022.269245","DOIUrl":null,"url":null,"abstract":"A sensitive, precise and accurate capillary electrophoresis method was developed for simultaneous determination of levamisole and oxyclozanide in pure sample and pharmaceutical preparation. Capillary electrophoresis was presented as a simple separation analytical method for the simultaneous analysis of the deliberated drugs within a shorter analytical run time. In this study, separation was achieved on fused silica capillary (30 cm - 50 µm internal diameter); background electrolyte solution consisted of phosphate buffer (40 mM, pH 7.9) and UV detection at 227 nm. The method showed to be linear (r 2 > 0.9998), precise (RSD <0.193%), accurate (recovery of 99.95% for levamisole and 100.12% for oxyclozanide), specific and robust. LOD and LOQ values were 0.099 µg mL -1 and 0.299 µg mL -1 respectively for levamisole and 0.075 µg mL -1 and 0.228 µg mL -1 respectively for oxyclozanide. The proposed method obtained well separation and had a perfect accuracy. The method was validated according to ICH guidelines and carried out for determination of the cited drugs in their pharmaceutical preparation.","PeriodicalId":7603,"journal":{"name":"Al-Azhar Journal of Pharmaceutical Sciences","volume":"35 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Al-Azhar Journal of Pharmaceutical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21608/ajps.2022.269245","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

A sensitive, precise and accurate capillary electrophoresis method was developed for simultaneous determination of levamisole and oxyclozanide in pure sample and pharmaceutical preparation. Capillary electrophoresis was presented as a simple separation analytical method for the simultaneous analysis of the deliberated drugs within a shorter analytical run time. In this study, separation was achieved on fused silica capillary (30 cm - 50 µm internal diameter); background electrolyte solution consisted of phosphate buffer (40 mM, pH 7.9) and UV detection at 227 nm. The method showed to be linear (r 2 > 0.9998), precise (RSD <0.193%), accurate (recovery of 99.95% for levamisole and 100.12% for oxyclozanide), specific and robust. LOD and LOQ values were 0.099 µg mL -1 and 0.299 µg mL -1 respectively for levamisole and 0.075 µg mL -1 and 0.228 µg mL -1 respectively for oxyclozanide. The proposed method obtained well separation and had a perfect accuracy. The method was validated according to ICH guidelines and carried out for determination of the cited drugs in their pharmaceutical preparation.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
毛细管电泳法同时测定制剂中左旋咪唑和羟氯胺的含量
建立了一种灵敏、精确、准确的毛细管电泳同时测定左旋咪唑和羟氯胺的方法。毛细管电泳是一种简便的分离分析方法,可在较短的分析时间内同时分析药物。在本研究中,分离是在熔融石英毛细管(30 cm - 50µm内径)上实现的;背景电解质溶液由磷酸盐缓冲液(40 mM, pH 7.9)和227 nm紫外检测组成。结果表明,该方法具有良好的线性(r 2 > 0.9998)、精密度(RSD <0.193%)、准确度(左旋咪唑回收率为99.95%,羟氯胺回收率为100.12%)、特异性和稳健性。左旋咪唑的LOD和LOQ分别为0.099µg mL -1和0.299µg mL -1,羟氯胺的LOD和LOQ分别为0.075µg mL -1和0.228µg mL -1。该方法分离效果好,精度高。该方法根据ICH指南进行了验证,并用于所引用药物制剂的测定。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
FORMULATION AND CHARACTERIZATIONS OF ROSUVASTATIN LOADED NANOSUSPENSION COMPARATIVE EVALUATION OF ANTICANCER AND ANTIBACTERIAL ACTIVITIES OF ENDOPHYTIC FUNGUS-DERIVED ZNO NANOPARTICLES AND CHEMICALLY SYNTHESIZED ZNO NANOPARTICLES PREPARATION AND EVALUATION OF SUSTAINED RELEASE MATRIX FORMULATIONS OF VORICONAZOLE PIM KINASES INHIBITORS AND PYRIMIDINE-BASED ANTICANCER AGENTS RECENT ADVANCES ON PYRIMIDINE DERIVATIVES AS ANTICANCER AGENTS.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1